{"id":809,"date":"2022-03-19T12:08:12","date_gmt":"2022-03-19T12:08:12","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=809"},"modified":"2022-03-19T12:09:05","modified_gmt":"2022-03-19T12:09:05","slug":"branaplam-nuevo-farmaco-de-novartis-investigado-en-el-ensayo-vibrant-hd-para-la-enfermedad-de-huntington","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2022\/03\/19\/branaplam-nuevo-farmaco-de-novartis-investigado-en-el-ensayo-vibrant-hd-para-la-enfermedad-de-huntington\/","title":{"rendered":"Branaplam, nuevo f\u00e1rmaco de Novartis investigado en el ensayo VIBRANT-HD para la Enfermedad de Huntington"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/03\/branaplam-1024x576.jpeg\" alt=\"\" class=\"wp-image-810\" srcset=\"https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/03\/branaplam-1024x576.jpeg 1024w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/03\/branaplam-300x169.jpeg 300w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/03\/branaplam-768x432.jpeg 768w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/03\/branaplam.jpeg 1366w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Novartis empieza el ensayo cl\u00ednico VIBRANT-HD en fase II. Est\u00e1 seleccionando personas en Europa y Norteam\u00e9rica para conocer la d\u00f3sis optima del f\u00e1rmaco Branaplam para investigar la reducci\u00f3n de la Huntingtina en pacientes con Enfermedad de Huntington. El primer f\u00e1rmaco administrado en forma oral que podr\u00eda conseguir estos efectos en las personas que padecen la enfermedad. <\/p>\n\n\n\n<p>LINK A LA NOTICIA:<\/p>\n\n\n\n<p><a href=\"https:\/\/ehamovingforward.org\/es\/2022\/03\/otra-vibrante-posibilidad-para-el-tratamiento-de-la-enfermedad-de-huntington\/\" target=\"_blank\" rel=\"noreferrer noopener\">Noticia en Moving Forward<\/a><\/p>\n\n\n\n<p>LINKA A LA CONFERENCIA DE PRESENTACI\u00d3N DE BRANAPLAM DE NOVARTIS:<\/p>\n\n\n\n<p><a rel=\"noreferrer noopener\" href=\"https:\/\/www.youtube.com\/watch?v=x2od9qXhI0o\" target=\"_blank\">Videoconferencia en el canal de youtube de Novartis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novartis empieza el ensayo cl\u00ednico VIBRANT-HD en fase II. Est\u00e1 seleccionando personas en Europa y Norteam\u00e9rica para conocer la d\u00f3sis optima del f\u00e1rmaco Branaplam para investigar la reducci\u00f3n de la Huntingtina en pacientes con Enfermedad de Huntington. El primer f\u00e1rmaco administrado en forma oral que podr\u00eda conseguir estos efectos en [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,131,4,9,132,5,58,130,8],"class_list":["post-809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-branaplam","tag-enfermedad-de-huntington","tag-enfermedades-raras","tag-ensayo-clinico","tag-huntingtons-disease","tag-neurodegenerativa","tag-novartis","tag-rare-diseases"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=809"}],"version-history":[{"count":2,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/809\/revisions"}],"predecessor-version":[{"id":812,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/809\/revisions\/812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media\/810"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}